Cardioprotective effects of prolyl hydroxylase inhibitors during reperfusion in myocardial infarction: A study using cardiosphere‐derived cells

Documenti analoghi

• Pharmacological prolyl hydroxylase inhibition enhances high‐intensity exercise capacity in mice
  di: Koji Takemura, et al.
  Pubblicazione: (2025)
• The endocrine product of renal (preglomerular) contractile pericytes depends on prolyl‐4‐hydroxylases 2 and 3
  di: Bettina K. M. Firmke, et al.
  Pubblicazione: (2026)
• 4D ultrasound‐based strain assessment of cardiac dysfunction in male rats with reperfused and nonreperfused myocardial infarction
  di: Ana C. M. Omoto, et al.
  Pubblicazione: (2024)
• Stellate ganglion neuromodulation: A novel approach to cardiac dysfunction in myocardial infarction and beyond
  di: Alex S.Y. Wang, et al.
  Pubblicazione: (2025)
• Cardioprotection via vagus nerve stimulation preconditioning: Reducing ischaemia–reperfusion injury and arrhythmic risk
  di: Feng Hu, et al.
  Pubblicazione: (2025)